John Hontz

Title: Innovations in Pharmaceutical Dosage: The Impact of John Hontz

Introduction: John Hontz, based in Plymouth, MN, is a prolific inventor with a remarkable portfolio of 19 patents. His work predominantly focuses on pharmaceutical dosage forms, specifically methods that enhance the absorption of medicaments through the oral cavity. Hontz's innovations are paving the way for more efficient drug delivery systems.

Latest Patents: Among his recent contributions are two notable patents: the Sublingual Buccal Effervescent and the Transmucosal Effervescent. Both inventions adapt a pharmaceutical dosage form to supply a medicament effectively for buccal, sublingual, or gingival absorption. These formulas contain an orally administrable medicament combined with an effervescent component to enhance absorption efficiency. Additionally, both patents disclose the use of a pH adjusting substance in conjunction with the effervescent to further promote drug absorption.

Career Highlights: John Hontz has made significant strides in pharmaceutical innovation, particularly during his tenure at companies like Cima Labs Inc. and Cephalon, Inc. His experience in these organizations has honed his skills in developing cutting-edge drug delivery systems that cater to various therapeutic needs.

Collaborations: Throughout his career, Hontz has worked alongside esteemed professionals such as Rajendra K. Khankari and Jonathan D. Eichman. These collaborations have fostered an environment of shared knowledge and expertise, further enriching Hontz's inventive contributions to the field.

Conclusion: John Hontz's dedication to improving pharmaceutical dosage forms exemplifies the spirit of innovation. His recent patents underscore the impact effective drug delivery methods can have on patient care. As Hontz continues to develop new technologies, the pharmaceutical landscape stands to benefit immensely from his visionary work.